Autopsy report · NCT01676090

IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population

“Participant enrolment was lower than expected”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 1 year 3 months before it stopped.
• 304 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Ipsen

Sponsor type

Industry

Conditions

IGF-1 Deficiency

Participants

304

Sites

9

Countries

Spain

Trials that died the same way

• Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer
  “Low enrolment rate” (72% match in meaning)
• A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)
  “Low enrolment” (72% match in meaning)
• Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor
  “Too low enrolment rate” (71% match in meaning)
• Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients
  “Enrolment was slowlier than expected.” (67% match in meaning)
• Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome
  “Only 2 participants were enrolled” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.